Katakura Industries Co., Ltd. · TSE:3001
Katakura Industries — FY2025 Earnings Presentation
22 slides from Katakura Industries's earnings presentation, Feb 27, 2026
Slide 1: Financial Results of 2025
Financial Results of 2025 (Code 3001, TSE Standard Market) February 27, 2026 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Slide 2: Contents
Contents Financial Results of 2025 1. Financial Highlights of 2025 3. Priority Issues to be Addressed Consolidated Income Statement Real Estate Consolidated Income Statement / Business Pharmaceuticals Segment Machinery Consolidated Balance Sheet Textiles Consolidated Statement of Cash Flows Initiati
Slide 3: 1. Financial Highlights of 2025
1. Financial Highlights of 2025 2
Slide 4: Consolidated Income Statement
Consolidated Income Statement Financial Results of 2025 Actual vs. (Million yen) 2025 Actual 2024 Actual YoY Change 2025 Forecast Forecast Ａ Ｂ A-B Ｃ A-C Net sales 40,652 39,424 1,228 40,700 (48) Operating income 5,855 4,124 1,731 5,000 855 Operating income ratio 14.4% 10.5% 3.9pt 12.3% 2.1pt Ordinar
Slide 5: Consolidated Income Statement / Business Segment
Consolidated Income Statement / Business Segment Financial Results of 2025 (Million yen) 2025 Actual 2024 Actual YoY Change Ａ Ｂ A-B Net sales Operating income Net sales Operating income Net sales Operating income Real Estate 11,699 4,395 11,139 4,269 ① 560 126 Pharmaceuticals 11,681 957 12,403 208 ②
Slide 6: Consolidated Balance Sheet
Consolidated Balance Sheet Financial Results of 2025 (Million yen) Dec 31, 2025 Dec 31, 2024 YoY Change A B A-B Current assets 58,526 58,437 89 Non-current assets 94,523 82,348 12,175 Property, plant and equipment 41,420 41,162 258 Intangible assets 512 566 (54) • Up due to the increase in Investmen
Slide 7: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows Financial Results of 2025 (Million yen) (Million yen) 2025 Actual 2024 Actual Cash and andcash cashequivalents equivalentsatatbeginning of period beginning of period 9,214 10,837 Operating cash Operating cashflows flows 8,244 5,643 Investing cash Investing flows
Slide 8: Capital Expenditures, Depreciation and R&D Expenditures
Capital Expenditures, Depreciation and R&D Expenditures Financial Results of 2025 (Million yen) 2025 Actual 2024 Actual YoY Change A B A-B Real Estate 940 705 235 Pharmaceuticals 876 414 462 Textiles 608 842 (234) Other Segments 570 221 349 Capital Expenditures 2,994 2,182 812 Real Estate 1,476 1,45
Slide 9: 2. 2026 Forecast
KATAKURA 2. 2026 Forecast
Slide 10: Consolidated Income Statement / Forecast
Consolidated Income Statement / Forecast Financial Results of 2025 (Million yen) 2026 Forecast 2025 Actual YoY Change A B A-B Net sales 41,100 40,652 448 Operating income 5,500 5,855 (355) Operating income ratio 13.4% 14.4% (1.0)pt Ordinary income 6,900 7,217 (317) Profit attributable to owners of p
Slide 11: Consolidated Income Statement / Business Segment Forecast
Consolidated Income Statement / Business Segment Forecast Financial Results of 2025 (Million yen) 2026 Forecast 2025 Actual YoY Change A B A-B Net sales Operating income Net sales Operating income Net sales Operating income Real Estate 12,000 4,500 11,699 4,395 ① 301 105 Pharmaceuticals 12,000 900 1
Slide 12: Capital Expenditures, Depreciation and R&D Expenditures Forecast
Capital Expenditures, Depreciation and R&D Expenditures Forecast Financial Results of 2025 (Million yen) 2026 Forecast 2025 Actual YoY Change A B A-B Real Estate 2,042 940 1,102 Pharmaceuticals 1,068 876 192 Textiles 668 608 60 Other Segments 406 570 (164) Capital Expenditures 4,184 2,994 1,190 Real
Slide 13: 3. Priority Issues to be Addressed
3. Priority Issues to be Addressed 12
Slide 14: Real Estate
Real Estate Financial Results of 2025 ■Outlook for FY2026 Sales and earnings will continue to increase due to proactive renovation and other initiatives. ◆ COCOON CITY ・ Sales are expected to increase due to higher rents resulting from tenant replacements and lease renewals. ・ Though Saitama Super A
Slide 15: Pharmaceuticals
Pharmaceuticals Financial Results of 2025 ■Outlook for FY2026 Sales will remain at the last yearʼs level, while earnings will decrease due to the impact of NHI drug price revisions and an increase in costs mainly due to rising raw material prices. ◆ Sales will remain at the last yearʼs level thanks
Slide 16: Machinery
Machinery Financial Results of 2025 ■Outlook for FY2026 While sales and earnings will decrease, the level of profit will remain stable as measures to improve profitability will take hold. ◆ Decreases in sales and earnings are expected mainly because production and sales will be delayed mainly due to
Slide 17: Textiles
Textiles Financial Results of 2025 ■Functional Fibers Business (Nitivy Co., Ltd.) ◆ Outlook for FY2026 Heat-resistant fibers: Sales for metal manufacturing and aircraft applications will grow. • Sales for overseas metal manufacturing applications will grow in Europe as well as in the U.S. • Sales fo
Slide 18: Initiatives to Grow Through M&A
Initiatives to Grow Through M&A Financial Results of 2025 ■Basic management policy Pursue initiatives to maximize the value of acquired companies - Make the most of each companyʼs strengths and utilize the Groupʼs platform and expertise to enhance their corporate value Enhance the foundation as grou
Slide 19: 4. Development of Foundational Structures
4. Development of Foundational Structures 18
Slide 20: Human Capital
Human Capital Financial Results of 2025 The Company believes that outstanding personnel should be actively promoted regardless of age, gender, background, and other factors, with all employees evaluated in a fair manner and given opportunities for promotion to managerial positions. Based on this bel
Slide 21: 5. Dividends and Dividend Policy
5. Dividends and Dividend Policy 20
Slide 22: Shareholder Returns (Dividends)
Shareholder Returns (Dividends) Financial Results of 2025 <Shareholder Return Policy> With regard to the distribution of profits, the Company strives to implement stable dividends and flexibly repurchase treasury shares as appropriate for the purpose of improving capital efficiency, etc. With regard